Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carboxymethylcellulose sodium is the sodium salt of carboxymethylcellulose (CMC), a water-soluble, anionic polysaccharide derived from cellulose by carboxymethylation of some of the hydroxyl groups of the glucopyranose monomers[1][4][5][6]. It appears as a white or slightly yellow, odorless, tasteless, hygroscopic powder or fiber that dissolves readily in water to form viscous solutions, acting as a thickening, emulsifying, stabilizing, or film-forming agent. Due to its biocompatibility, non-toxicity, and ability to hydrate and form gels, it is widely used in pharmaceuticals (e.g., as an artificial tear in eye drops, wound dressing, binder in tablets), foods (as a thickener and stabilizer), and numerous industrial applications. It does not have any known intrinsic therapeutic bioactivity and is not a biological molecular target for drugs[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carboxymethylcellulose sodium (CMC-Na).